Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00577356
What this trial is testing

Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Benaroya Research Institute 6
Testing effectiveness (Phase 2)UnknownNCT00657982
What this trial is testing

Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Sheba Medical Center 15
Not applicableLooking for participantsNCT06982469
What this trial is testing

High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy

Who this might be right for
Prostate CancerProstatectomyLocal Recurrence of Malignant Tumor of Prostate+2 more
Clinica Universidad de Navarra, Universidad de Navarra 20
Not applicableUnknownNCT04278261
What this trial is testing

Comparison H-FIRE and Laparoscopic RP in Treating Men With Localized Prostate Cancer

Who this might be right for
Prostate CancerTreatment
Shanghai East Hospital 216
Testing effectiveness (Phase 2)Study completedNCT00528866
What this trial is testing

Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 80
Not applicableUnknownNCT00573586
What this trial is testing

Treatment of Localized Prostate Cancer With High Intensity Focused Ultrasound Using the Sonablate® 500 System in Canada

Who this might be right for
Prostate Cancer
SonaCare Medical 20
Testing effectiveness (Phase 2)Study completedNCT00225420
What this trial is testing

Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT03570827
What this trial is testing

Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8+3 more
Mayo Clinic 53
Early research (Phase 1)Study completedNCT01420250
What this trial is testing

Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 20
Not applicableLooking for participantsNCT07422597
What this trial is testing

Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prostate Cancer

Who this might be right for
Prostate Cancer
Norwegian University of Science and Technology 1,016
Testing effectiveness (Phase 2)Study completedNCT04733768
What this trial is testing

18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Alberta 100
Early research (Phase 1)Looking for participantsNCT05997615
What this trial is testing

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

Who this might be right for
Hormone-refractory Prostate Cancer
Astellas Pharma Global Development, Inc. 437
Testing effectiveness (Phase 2)Study completedNCT02770391
What this trial is testing

Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 54
Not applicableLooking for participantsNCT07560748
What this trial is testing

Prospective Prostate Cancer Infrastructure

Who this might be right for
High Risk Localized Prostate CancerSynchronous Metastatic Hormone-Sensitive Prostate Cancer
Radboud University Medical Center 700
Early research (Phase 1)Study completedNCT00032825
What this trial is testing

Ketoconazole Plus Docetaxel to Treat Prostate Cancer

Who this might be right for
Prostatic Neoplasms
National Cancer Institute (NCI) 674
Not applicableWithdrawnNCT02597894
What this trial is testing

Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy

Who this might be right for
Stage III Prostate Adenocarcinoma
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02023697
What this trial is testing

Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone

Who this might be right for
Prostatic Neoplasms
Bayer 391
Not applicableStudy completedNCT00898274
What this trial is testing

Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants

Who this might be right for
Precancerous ConditionProstate Cancer
Case Comprehensive Cancer Center 40
Not applicableActive Not RecruitingNCT05958082
What this trial is testing

Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients With High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Henry Ford Health System 50
Large-scale testing (Phase 3)Ended earlyNCT00949962
What this trial is testing

Post-operative or Early Salvage XRT and ADT for High Risk PCa

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 87
Next Page